Nursing Department
Taipei, 110, Taiwan
NCT Number: NCT06999421
This randomized controlled trial evaluates the effectiveness of a robot-assisted digital education program for pregnant women diagnosed with gestational diabetes mellitus (GDM). The intervention aims to reduce anxiety, improve health literacy, and increase satisfaction and acceptance of digital health technologies. Participants are randomly assigned to either a robot-assisted education group or a conventional tablet-based video education group. Outcome measures include anxiety scores, health literacy scores, and educational satisfaction.
Looking for future studies?
Notify Me21 year–50 year
Female
Interventional
Not applicable
Taipei, 110, Taiwan
This study implemented a robot-assisted digital education method for teaching about gestational diabetes mellitus (GDM) that was intended to reduce anxiety and encourage healthy behaviors among pregnant women. A randomized controlled trial was conducted to assess the effectiveness of the intervention, where 66 pregnant women from a single hospital were randomly assigned to either the experimental group (n = 32) or the control group (n = 34). The experimental group received health education about GDM using a robot, while the control group received the same health education through video presentations on a tablet. The results showed that the implemented robot-assisted digital education method not only reduced anxiety levels among pregnant women, but also influences their health education satisfaction, health literacy, and acceptance of technology. In the global information age, this study can serve as a reference for educators and researchers at medical institutions interested in tracking long-term health education through technological tools.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A humanoid educational robot that provides GDM-related content using animated videos, emotional facial expressions, gesture movements, and voice/touch-based interaction. Designed to increase engagement, reduce anxiety, and improve health literacy among pregnant women.
A standard touchscreen tablet used to deliver pre-recorded educational videos on GDM. This intervention provides passive viewing without any robot interaction or feedback.
Time frame: Immediately post-intervention
Anxiety levels were assessed using a Likert-type scale ranging from 1 (no symptoms) to 5 (severe anxiety).
Time frame: Immediately post-intervention
Health literacy, which also used a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree)
Time frame: Immediately post-intervention
Health education satisfaction was using a Likert scale ranging from 1 (very satisfied) to 5 (very dissatisfied)
Time frame: Immediately post-intervention
technology acceptance of the pregnant women was measured using another Likert scale ranging from 1 (strongly agree) to 5 (strongly disagree)
Taipei Medical University
Other
The Impact of Robot-assisted Digital Education on Prenatal Women's Health Literacy: A Randomized Controlled Trial
Acronym: RADE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07652554
Diabetes Mellitus, Diabetes, Gestational
Moscow, Russia
View Trial DetailsNCT07618286
Adherence Interventions, Behavior
Istanbul, Üsküdar, Turkey (Türkiye)
View Trial DetailsNCT07582471
Diabetes Mellitus, Diabetes, Gestational
Lodhran, Punjab Province, Pakistan
View Trial DetailsNCT07051681
Diabetes Mellitus, Diabetes, Gestational
Maltepe, Istanbul, Turkey (Türkiye)
View Trial Details